No increases in hospital-acquired VRE bloodstream infections seen after screening ceased

In Alberta, Canada, the rate of hospital-acquired vancomycin-resistant enterococci bloodstream infections remained consistent regardless of patient risk, even in units that changed or discontinued screening protocols, according to a study.
“Based on recommendations from the Canadian Consensus Development Conference on Surveillance and Screening for Antimicrobial Resistant Organisms, new vancomycin-resistant enterococci (VRE) screening protocols were implemented for all acute-care facilities in Alberta, which eliminated routine admission screening and focused on high-risk patient care units,”

In Alberta, Canada, the rate of hospital-acquired vancomycin-resistant enterococci bloodstream infections remained consistent regardless of patient risk, even in units that changed or discontinued screening protocols, according to a study.
“Based on recommendations from the Canadian Consensus Development Conference on Surveillance and Screening for Antimicrobial Resistant Organisms, new vancomycin-resistant enterococci (VRE) screening protocols were implemented for all acute-care facilities in Alberta, which eliminated routine admission screening and focused on high-risk patient care units,”